求翻译

初学者

  UK experience with TACE
         –  Requirement for more refined selection of patients for TACE
   Development of the Hepatic Arterial Prognosis score(HAP)
   UK experience with sorafenib
   Can we select patients more appropriately for TACE or systemic therapy?